The Quantellect read.As of Nov 19, 2026, 21 active firms cover HCA Healthcare, Inc: 15 rate it Buy or better, 5 sit at Neutral, and 1 rate it Sell or worse, a buy consensus. Targets span $380.00 to $590.00, a moderate spread. The average target of $478.05 sits 1% above the current $475.56. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 13 to 15 over recent months. On the fundamentals, the Street sees consensus EPS building from about $7.49 next quarter toward $31.30 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS21 active firms
Buy
Strong Buy00%
Buy1571%
Neutral524%
Sell15%
Strong Sell00%
Based on 21 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$478.05
+0.5% upside
Average target across 21 active firms as of Nov 19, 2026 vs $475.56 current
Highest Target$590.00
Average Target$478.05
Lowest Target$380.00
Detailed analyst forecasts for HCA
Showing 1–21 of 21 named analysts shown · 21 active firms in the rating projection
As of Nov 19, 2026, 15 of 21 active firms rate HCA a Buy (5 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HCA EPS & revenue forecast
EPS · NEXT QUARTER
$7.49
Range $6.93 – $7.94 · 13 analysts · +5% YoY
Next period, 13 analysts expect HCA Healthcare, Inc. to earn $7.49 a share (range $6.93 – $7.94), versus $7.15 a year earlier. Full-year consensus is $30.05, growing to $31.30 the year after.
REVENUE · NEXT QUARTER
$19.9B
Range $19.7B – $20.1B · 13 analysts · +4% YoY
Revenue is expected to reach $19.9B (range $19.7B – $20.1B), +4.1% year-over-year. Full-year consensus is $79.2B, rising to $81.7B next year.
Top analysts covering HCA Healthcare, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HCA.
#1
Stephen Baxter
Wells Fargo · Rank #63
Neutral
$381.00-19.9% to target
Overall win rate
47%
+ Follow
#2
DM
David Macdonald
Truist Securities · Rank #111
Buy
$495.00+4.1% to target
Overall win rate
50%
+ Follow
#3
Ben Hendrix
RBC Capital · Rank #150
Buy
$521.00+9.6% to target
Overall win rate
44%
+ Follow
#4
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$525.00+10.4% to target
Overall win rate
37%
+ Follow
#5
Brian Tanquilut
Jefferies · Rank #280
Buy
$450.00-5.4% to target
Overall win rate
46%
+ Follow
HCA stock forecast FAQ
What is HCA's average 12-month price target?+
The 21 active firms with a live target average $478.05 for HCA Healthcare, Inc. over the next 12 months, ranging from a $590.00 high to a $380.00 low, as of Nov 19, 2026.
Is HCA stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 21 active firms as of Nov 19, 2026, 15 rate it Buy or Strong Buy, 5 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HCA?+
The Street-high target is $590.00 (Jefferies), and the Street-low is $380.00 (Morgan Stanley). The average of all 21 active-firm targets is $478.05.
How many active Wall Street firms cover HCA?+
21 active firms have a recognized rating on HCA Healthcare, Inc. as of Nov 19, 2026, and 21 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HCA?+
Among analysts who currently cover HCA, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Neutral with a $381.00 target.
What is HCA Healthcare, Inc.'s projected EPS for next quarter?+
The consensus estimate is $7.49 per share (range $6.93 – $7.94) across 13 analysts. Full-year EPS is projected at $30.05, rising to $31.30 the following year.
How much revenue is HCA Healthcare, Inc. expected to report next quarter?+
Consensus revenue is $19.9B (range $19.7B – $20.1B). Full-year revenue is projected at $79.2B, growing to $81.7B next year.
Have analysts been upgrading or downgrading HCA lately?+
As of Nov 19, 2026, 15 of 21 active firms rate HCA a Buy (5 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HCA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.